Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Isis' antisense drugs were highlighted with eight presentations (including three oral talks ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE